The bill establishes a Minnesota Prescription Drug Purchasing Program, which will be administered by the commissioner of human services. This program aims to provide prescription drugs to medical assistance and MinnesotaCare enrollees at the lowest possible cost. The commissioner is tasked with promoting health through discounted drug purchases, maintaining a list of effective drugs, administering benefits, and managing pharmacy claims. Additionally, the commissioner is authorized to negotiate prices with drug manufacturers and develop a preferred drug list, with the option to contract with external entities for assistance during specific plan years.

Furthermore, the bill mandates the commissioner to seek necessary federal approvals for the program's implementation, which is set to take effect on January 1, 2026, or upon federal approval, whichever is later. It also requires the commissioner to develop recommendations for expanding the program to include enrollees from health plan companies that contract with the state, with a report due by December 15, 2026, to relevant legislative committees.